Pfizer/BioNTech say vaccine effective against UK, South Africa virus mutations
- Pfizer/BioNTech say preliminary findings “do not indicate the need for a new vaccine to address the emerging variants”
- Companies “prepared to respond” if new strain is shown to be able to evade the immunity of the vaccine
